SG11201707719WA - Dispersible dosage form - Google Patents

Dispersible dosage form

Info

Publication number
SG11201707719WA
SG11201707719WA SG11201707719WA SG11201707719WA SG11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA
Authority
SG
Singapore
Prior art keywords
dosage form
dispersible dosage
dispersible
dosage
Prior art date
Application number
SG11201707719WA
Other languages
English (en)
Inventor
Leonie Wagner-Hattler
Maxim Puchkov
Jörg Huwyler
Tanja Stirnimann
Quijano Carolina Diaz
Joachim Schoelkopf
Patrick A C Gane
Daniel E Gerard
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of SG11201707719WA publication Critical patent/SG11201707719WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1664Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00Compounds of calcium, strontium, or barium
    • C01F11/18Carbonates
    • C01F11/185After-treatment, e.g. grinding, purification, conversion of crystal morphology
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/10Solid density
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/12Surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/14Pore volume

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Geology (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
SG11201707719WA 2015-03-20 2016-03-15 Dispersible dosage form SG11201707719WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15160194.5A EP3069713A1 (de) 2015-03-20 2015-03-20 Dispergierbare dosierungsform
US201562203948P 2015-08-12 2015-08-12
PCT/EP2016/055590 WO2016150773A1 (en) 2015-03-20 2016-03-15 Dispersible dosage form

Publications (1)

Publication Number Publication Date
SG11201707719WA true SG11201707719WA (en) 2017-10-30

Family

ID=52686285

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707719WA SG11201707719WA (en) 2015-03-20 2016-03-15 Dispersible dosage form

Country Status (16)

Country Link
US (1) US10617648B2 (de)
EP (2) EP3069713A1 (de)
JP (1) JP2018510162A (de)
KR (1) KR102119074B1 (de)
CN (1) CN107405308A (de)
AU (1) AU2016236390A1 (de)
BR (1) BR112017019927A2 (de)
CA (1) CA2978032C (de)
CO (1) CO2017009959A2 (de)
CR (1) CR20170427A (de)
MX (1) MX2017011774A (de)
PH (1) PH12017501546A1 (de)
RU (1) RU2733757C2 (de)
SG (1) SG11201707719WA (de)
TW (1) TW201641120A (de)
WO (1) WO2016150773A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260115A1 (de) * 2016-06-21 2017-12-27 Omya International AG Verfahren zur herstellung einer darreichungsform
EP3260114A1 (de) * 2016-06-21 2017-12-27 Omya International AG Verfahren zur herstellung einer darreichungsform
EP3311665A1 (de) * 2016-10-21 2018-04-25 Omya International AG Verwendung von oberflächenreaktivem calziumcarbonat zur reparatur übersättigter wässriger systeme
CN107255602B (zh) * 2017-06-06 2020-05-05 武汉烽火锐拓科技有限公司 在线测量疏松体密度的方法及装置
CA3068308A1 (en) * 2017-06-29 2019-01-03 Solenis Technologies Cayman, L.P. Water stable granules and tablets
JP6719779B2 (ja) * 2017-07-27 2020-07-08 白石工業株式会社 炭酸カルシウムを含む食品
JP6959669B2 (ja) * 2017-07-27 2021-11-02 白石工業株式会社 炭酸カルシウム、食品添加用炭酸カルシウム製剤及び食品
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (de) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
PL149493B1 (en) 1985-04-12 1990-02-28 Method of obtaining a tablet capable to buoy over surface of gastric juice
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
DE69428707T2 (de) 1993-08-20 2002-07-11 Nippon Shinyaku Co Ltd Im magen verbleibende zubereitung, quellender formkörper und herstellungsverfahren
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
AU2001284444B2 (en) 2000-09-06 2006-05-25 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
FI20061146A0 (fi) * 2006-11-10 2006-12-21 Iprbox Oy Rakeita, tabletteja ja rakeistusmenetelmä
PT2070991E (pt) 2007-12-12 2010-10-25 Omya Development Ag Processo para produção de carbonato de cálcio precipitado reagido em superfície
EP2168572A1 (de) 2008-09-30 2010-03-31 Omya Development Ag Neuer Wirkstoffträger mit kontrollierter Freisetzung
ME01449B (me) 2009-06-15 2014-04-20 Omya Development Ag POSTUPAK ZA DOBIJANJE POVRŠINSKI IZREAGOVANOG KALCIJUM KARBONATA l NJEGOVA UPOTREBA
ATE545682T1 (de) 2009-06-15 2012-03-15 Omya Development Ag Verfahren zur herstellung eines an der oberfläche reagierten calciumcarbonats, das eine schwache säure anwendet
CN102665764A (zh) * 2009-12-22 2012-09-12 Fmc有限公司 可用作可再压实药物赋形剂的微晶纤维素和碳酸钙组合物
EP2679638B1 (de) 2012-06-28 2015-09-02 Omya International AG Wässriges Mineral mit hohem Feststoffanteil und/oder Füller und/oder Pigmentsuspension in einer sauren pH-Umgebung
EP2719376B1 (de) 2012-10-12 2015-03-04 Omya International AG Gastroretentive Arzneimittelformulierung und Verabreichungssysteme und ihre Herstellungsverfahren unter Verwendung von funktionalisiertem Calciumcarbonat
ES2628371T3 (es) 2012-10-12 2017-08-02 Omya International Ag Formulación de forma farmacéutica sólida de disgregación rápida que comprende carbonato de calcio funcionalizado y método para su fabricación
EP2997833B1 (de) * 2014-09-22 2018-01-31 Omya International AG Oberflächenreaktives Calciumkarbonat zur Verwendung als Trennmittel
EP3034070A1 (de) * 2014-12-18 2016-06-22 Omya International AG Verfahren zur Herstellung eines pharmazeutischen Abgabesystems

Also Published As

Publication number Publication date
CN107405308A (zh) 2017-11-28
KR20170129232A (ko) 2017-11-24
RU2733757C2 (ru) 2020-10-06
CA2978032A1 (en) 2016-09-29
KR102119074B1 (ko) 2020-06-05
CA2978032C (en) 2020-09-01
CO2017009959A2 (es) 2018-01-05
JP2018510162A (ja) 2018-04-12
US10617648B2 (en) 2020-04-14
AU2016236390A1 (en) 2017-11-09
RU2017134394A3 (de) 2019-04-03
BR112017019927A2 (pt) 2018-06-12
CR20170427A (es) 2018-04-02
TW201641120A (zh) 2016-12-01
RU2017134394A (ru) 2019-04-03
EP3069713A1 (de) 2016-09-21
WO2016150773A1 (en) 2016-09-29
MX2017011774A (es) 2017-12-04
EP3270899A1 (de) 2018-01-24
US20180078506A1 (en) 2018-03-22
PH12017501546A1 (en) 2018-02-05

Similar Documents

Publication Publication Date Title
ZA201708081B (en) Preparation comprising arabinoxylo-oligosaccharides
HK1243644A1 (zh) 可分散組合物
SG11201707719WA (en) Dispersible dosage form
GB201515018D0 (en) Barrier
GB201514758D0 (en) Formulation
HK1231325A1 (zh) 改善的防害蟲屏障
IL258243A (en) Barrier
HUE054584T2 (hu) Maropitant készítmény
GB201607548D0 (en) Solid dosage form
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
HRP20181406T1 (hr) Farmaceutski dozni oblici
GB201500661D0 (en) Rake devices
IL242773A0 (en) Assembly kit
GB201514803D0 (en) Easy see mouse
GB201507279D0 (en) Odontalgic preparation
GB201514014D0 (en) Formulation
GB201508113D0 (en) Holdtrite mouse
GB201502709D0 (en) Barrier
GB201504662D0 (en) Formulation
GB201505126D0 (en) Concept four
GB201504142D0 (en) Option administration
AU2015003V (en) PencilGL Guichenotia macrantha